Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Vigil Neuroscience Inc. logo

Vigil Neuroscience Inc. (VIGL)

Market Closed
23 May, 20:00
NASDAQ (NGS) NASDAQ (NGS)
NASDAQ (NGS) NASDAQ (NGS) Primary
$
7. 89
+0.01
+0.13%
$
367.77M Market Cap
- P/E Ratio
0% Div Yield
3,705,000 Volume
-2.17 Eps
$ 7.88
Previous Close
Day Range
7.87 7.9
Year Range
1.31 7.95

Summary

VIGL closed Friday higher at $7.89, an increase of 0.13% from Thursday's close, completing a monthly increase of 270.42% or $5.76. Over the past 12 months, VIGL stock gained 364.12%.
VIGL is not paying dividends to its shareholders.
The last earnings report, released on May 07, 2025, exceeded the consensus estimates by 0.06%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track VIGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

VIGL Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

NEW YORK , June 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: TuHURA Biosciences, Inc. (NASDAQ: HURA)'s  merger with Kineta, Inc. If you are a TuHURA shareholder, click here to learn more about your legal rights and options . Vigil Neuroscience, Inc. (NASDAQ: VIGL)'s  sale to Sanofi.

Prnewswire | 1 day ago
Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 26.9% in Vigil Neuroscience (VIGL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks | 1 day ago
VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm

VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm

PHILADELPHIA , June 4, 2025 /PRNewswire/ -- The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Vigil Neuroscience, Inc. ("Vigil") (NASDAQ: VIGL) shareholders. Click here for additional information about your legal rights and options: Click Here On May 21, 2025, Vigil announced that it had agreed to be acquired by Sanofi at an upfront price of $8.00 per share in cash plus a non-transferable contingent value right (CVR) worth an additional $2.00 in cash upon the achievement of certain milestones.

Prnewswire | 6 days ago

Vigil Neuroscience Inc. Dividends

VIGL is not paying dividends to its shareholders.

Vigil Neuroscience Inc. Earnings

7 May 2025 Date
-
Cons. EPS
-
EPS
13 Mar 2025 Date
-
Cons. EPS
-
EPS
7 Nov 2024 Date
-
Cons. EPS
-
EPS
13 Aug 2024 Date
-
Cons. EPS
-
EPS
9 May 2024 Date
-
Cons. EPS
-
EPS
VIGL earnings
VIGL is not paying dividends to its shareholders.
7 May 2025 Date
-
Cons. EPS
-
EPS
13 Mar 2025 Date
-
Cons. EPS
-
EPS
7 Nov 2024 Date
-
Cons. EPS
-
EPS
13 Aug 2024 Date
-
Cons. EPS
-
EPS
9 May 2024 Date
-
Cons. EPS
-
EPS
VIGL earnings

Vigil Neuroscience Inc. (VIGL) FAQ

What is the stock price today?

The current price is $7.89.

On which exchange is it traded?

Vigil Neuroscience Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is VIGL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 367.77M.

Has Vigil Neuroscience Inc. ever had a stock split?

No, there has never been a stock split.

Vigil Neuroscience Inc. Profile

Biotechnology Industry
Healthcare Sector
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D. CEO
NASDAQ (NGS) Exchange
92673K108 Cusip
US Country
69 Employees
- Last Dividend
- Last Split
7 Jan 2022 IPO Date
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address: 1 Broadway
Phone: 857 254 4445
Affiliate Program About Report a Bug Terms Privacy Help Contact Us
2025 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark
Logo Logo
Sign Up
Sign In